This report aims to provide countries and suppliers with estimates of the global market for antiretroviral (ARV) medicines in low- and middle-income countries for 2020-2024. It includes estimates of the global demand for active pharmaceutical ingredients (APIs) and ARVs for adults receiving first-line ART to enable suppliers to plan and manage their manufacturing capacities accordingly.
This report aims to provide countries and suppliers with estimates of the global market for antiretroviral (ARV) medicines in low- and middle-income countries for 2020-2024. It includes estimates of the global demand for active pharmaceutical ingredients (APIs) and ARVs for adults receiving first-line ART to enable suppliers to plan and manage their manufacturing capacities accordingly.